Alerts will be sent to your verified email
Verify EmailONYX
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Onyx Biotec is engaged in the business of Manufacturing of Pharmaceutical Products such as sterile water ampoule, dry injection, dry syrup etc. Its products are being processed and manufactured in accordance with best Food and Drug Administration (FDA) practices available globally. Its system and product are tested constantly at each level to ensure international standards of quality in-house and FDA Certified Laboratories. Its core business is focused on providing end-to-end product development and manufacturing solutions to its clients.
Onyx Biotec major competitors are Suven Pharma, JB Chem & Pharma, Lasa Supergenerics, Makers Laboratories, Biofil Chem & Pharma, Rajnish Wellness, Bharat Immunological.
Market Cap of Onyx Biotec is ₹91 Crs.
While the median market cap of its peers are ₹90 Crs.
Onyx Biotec seems to be less financially stable compared to its competitors.
Altman Z score of Onyx Biotec is 2.43 and is ranked 4 out of its 8 competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | ||||||||||||||||||
Investor Presentation | ||||||||||||||||||
Conference Call | ||||||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|